UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033175
Receipt number R000037833
Scientific Title Comparison of visual outcomes between bilateral implantation of a trifocal intraocular lens (IOL) and combined implantation of a bifocal IOL with different near addition power: a prospective nonrandomized study
Date of disclosure of the study information 2018/06/28
Last modified on 2018/06/28 11:32:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of visual outcomes between bilateral implantation of a trifocal intraocular lens (IOL) and combined implantation of a bifocal IOL with different near addition power: a prospective nonrandomized study

Acronym

Bilateral trifocal IOLs versus
combined bifocal IOLs

Scientific Title

Comparison of visual outcomes between bilateral implantation of a trifocal intraocular lens (IOL) and combined implantation of a bifocal IOL with different near addition power: a prospective nonrandomized study

Scientific Title:Acronym

Bilateral trifocal IOLs versus
combined bifocal IOLs

Region

Japan


Condition

Condition

Cataract

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare binocular visual outcomes between patients implanted bilaterally with a new trifocal intraocular lens (IOL) and patients implanted with bifocal IOLs having +3.0 diopter (D) near addition power in the dominant eye and +4.0D in the nondominant eye.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1) Binocular uncorrected and corrected visual acuity (VA) at various distances measured using the all-distance vision tester (KOWA AS-15),
2) Contrast visual acuity (CAT-2000) with and without glare,
3) Near stereoacuity (Titmus stereo test),
4) Number (%) of patients who reported glare and halo symptoms
5) Wavefront higher-order aberrations (HOAs); total, coma-like, and spherical-like HOAs
6) Pupil diameter, corneal astigmatism, manifest spherical equivalent value

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

A trifocal IOL group (n=32) implanted bilaterally with a new trifocal IOL (Alcon PanOptix; TFNT00).

Interventions/Control_2

A combined bifocal group (n=46) implanted with a bifocal IOL with +3.0D near addition power (SN60D1) in the dominant eye and +4.0D near addition power (SN60D3) in the nondominant eye.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

All patients who elected to undergo bilateral phacoemulsification and implantation of multifocal IOLs

Key exclusion criteria

Preoperative exclusion criteria were patients with any pathology of the cornea, macula or optic nerve; opaque media other than cataract; history of ocular inflammation or surgery; corneal astigmatism of 1.0 D or more; marked irregular corneal astigmatism; amblyopia; patients who had participated in another clinical trial; and any difficulties with examinations, analyses, or follow-up. Intraoperative exclusion criteria were a small pupillary diameter that required pupil expansion procedures and eventful surgery.

Target sample size

78


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ken Hayashi

Organization

Hayashi Eye Hospital

Division name

Department of Ophthalmology

Zip code


Address

4-23-35, Hakataekimae, Hakata-ku, Fukuoka, Japan

TEL

092-431-1680

Email

hayashi-ken@hayashi.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ken Hayashi

Organization

Hayashi Eye Hospital

Division name

Department of Ophthalmology

Zip code


Address

4-23-35, Hakataekimae, Hakata-ku, Fukuoka, Japan

TEL

092-431-1680

Homepage URL


Email

hayashi-ken@hayashi.or.jp


Sponsor or person

Institute

Hayashi Eye Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

林眼科病院(福岡県)Hayashi Eye Hospital


Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 12 Month 25 Day

Date of IRB


Anticipated trial start date

2014 Year 01 Month 30 Day

Last follow-up date

2017 Year 01 Month 18 Day

Date of closure to data entry

2017 Year 01 Month 18 Day

Date trial data considered complete

2018 Year 06 Month 04 Day

Date analysis concluded

2018 Year 06 Month 11 Day


Other

Other related information



Management information

Registered date

2018 Year 06 Month 28 Day

Last modified on

2018 Year 06 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037833


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name